Women who have inherited mutations in the BRCA1 or BRCA2 genes (BRCA-1/2) have substantially elevated lifetime risks for developing breast (80–90% lifetime risk) and/or ovarian cancer (18–40% lifetime risk) [1]. Here, BRCA2 is linked to ovarian carcinoma.